Literature DB >> 12037065

Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov.

Tom Coenye1, Johan Goris, Theodore Spilker, Peter Vandamme, John J LiPuma.   

Abstract

Using a polyphasic approach (including cellular protein and fatty acid analysis, biochemical characterization, 16S ribosomal DNA sequencing, and DNA-DNA hybridizations), we characterized 51 bacterial isolates recovered from respiratory secretions of cystic fibrosis (CF) patients. Our analyses showed that 24 isolates belong to taxa that have so far not (or only rarely) been reported from CF patients. These taxa include Acinetobacter sp., Bordetella hinzii, Burkholderia fungorum, Comamonas testosteroni, Chryseobacterium sp., Herbaspirillum sp., Moraxella osloensis, Pandoraea genomospecies 4, Ralstonia gilardii, Ralstonia mannitolilytica, Rhizobium radiobacter, and Xanthomonas sp. In addition, one isolate most likely represents a novel Ralstonia species, whereas nine isolates belong to novel taxa within the alpha-PROTEOBACTERIA: Eight of these latter isolates are classified into the novel genus Inquilinus gen. nov. as Inquilinus limosus gen. nov., sp. nov., or as Inquilinus sp. The remaining 17 isolates are characterized as members of the family ENTEROBACTERIACEAE: The recovery of these species suggests that the CF lung is an ecological niche capable of supporting the growth of a wide variety of bacteria rarely seen in clinical samples. Elucidation of the factors that account for the association between these unusual species and the respiratory tract of CF patients may provide important insights into the pathophysiology of CF infection. Because accurate identification of these organisms in the clinical microbiology laboratory may be problematic, the present study highlights the utility of reference laboratories capable of identifying unusual species recovered from CF sputum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037065      PMCID: PMC130740          DOI: 10.1128/JCM.40.6.2062-2069.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies.

Authors:  M I Daneshvar; D G Hollis; A G Steigerwalt; A M Whitney; L Spangler; M P Douglas; J G Jordan; J P MacGregor; B C Hill; F C Tenover; D J Brenner; R S Weyant
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples.

Authors:  T Coenye; S Laevens; A Willems; M Ohlén; W Hannant; J R Govan; M Gillis; E Falsen; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

4.  Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov.

Authors:  M Drancourt; C Bollet; A Carta; P Rousselier
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

5.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Authors:  A Nemec; T De Baere; I Tjernberg; M Vaneechoutte; T J van der Reijden; L Dijkshoorn
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

7.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Phenotypic and phylogenetic characterization of Burkholderia (Pseudomonas) sp. strain LB400.

Authors:  M G Fain; J D Haddock
Journal:  Curr Microbiol       Date:  2001-04       Impact factor: 2.188

Review 9.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov. and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary specimens.

Authors:  P Vandamme; M Vancanneyt; B Pot; L Mels; B Hoste; D Dewettinck; L Vlaes; C van den Borre; R Higgins; J Hommez
Journal:  Int J Syst Bacteriol       Date:  1992-07
View more
  84 in total

1.  Species identification of clinical Prevotella isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Ingrid Wybo; Oriane Soetens; Annelies De Bel; Fedoua Echahidi; Ellen Vancutsem; Kristof Vandoorslaer; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Authors:  Yvonne J Huang; Craig E Nelson; Eoin L Brodie; Todd Z Desantis; Marshall S Baek; Jane Liu; Tanja Woyke; Martin Allgaier; Jim Bristow; Jeanine P Wiener-Kronish; E Rand Sutherland; Tonya S King; Nikolina Icitovic; Richard J Martin; William J Calhoun; Mario Castro; Loren C Denlinger; Emily Dimango; Monica Kraft; Stephen P Peters; Stephen I Wasserman; Michael E Wechsler; Homer A Boushey; Susan V Lynch
Journal:  J Allergy Clin Immunol       Date:  2010-12-30       Impact factor: 10.793

Review 3.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  Presence of opportunistic bacteria (Rhizobium spp.) with potential for molecular misdiagnosis among canine and feline clinical samples.

Authors:  Maria-Dolores Tabar; Laura Altet; Xavier Roura; Armand Sánchez; Lluís Ferrer; Olga Francino
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

5.  Comamonas testosteroni peritonitis secondary to dislocated intrauterine device and laparoscopic intervention in a continuous ambulatory peritoneal dialysis patient.

Authors:  Eda Altun; Bülent Kaya; Onur Taktakoglu; Refika Karaer; Saime Paydas; Mustafa Balal; Neslihan Seyrek
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

6.  Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.

Authors:  Mike Wilton; Megan J Q Wong; Le Tang; Xiaoye Liang; Richard Moore; Michael D Parkins; Shawn Lewenza; Tao G Dong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

7.  Airway colonization by Acrophialophora fusispora in patients with cystic fibrosis.

Authors:  Bernard Cimon; Svetlana Challier; Hugues Béguin; Jacqueline Carrère; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis.

Authors:  Christine Segonds; Sandrine Paute; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Airway infection with a novel Cupriavidus species in persons with cystic fibrosis.

Authors:  Wiltrud Maria Kalka-Moll; John J LiPuma; Frank J Accurso; Georg Plum; Silke van Koningsbruggen; Peter Vandamme
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

10.  Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.

Authors:  Tom Coenye; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.